多重呼吸道病毒检测对成人急性诊疗中抗菌药物消耗的影响:一项随机临床试验
该随机对照试验纳入998名因呼吸道症状、发热、胸痛或一般状况差就诊于急诊科的成人,比较24小时(干预组496例)与7天(对照组502例)获得多重PCR病毒检测结果对住院时长和30天内抗菌药物消耗的影响。结果显示两组住院时长(4.2天 vs 4.1天,差异0.1,95%CI -0.5至0.6,P=0.810)和抗菌药物使用天数(11.3天 vs 10.4天,差异0.9,95%CI -0.6至2.4,P=0.235)均无显著差异。
要点
- 24小时内获得多重PCR呼吸道病毒检测结果未缩短住院时长。
- 快速病毒检测未减少30天内抗菌药物使用天数。
- 研究纳入急诊成人呼吸道症状、发热、胸痛或一般状况差者。
核心结论
- 24小时内可获取的多重PCR呼吸道病毒检测未减少成人急性诊疗中的抗菌药物消耗或住院时长。
研究设计与样本
- 在三级医院急诊科开展1:1随机对照临床试验,纳入998名有呼吸道症状、发热、胸痛或一般状况差的成人。
- 干预组496例在24小时内获得多重PCR结果,对照组502例在7天后获得结果。
- 主要结局为入组后30天内的住院时长和抗菌药物消耗。
主要发现
- 998例中841例(84%)入组时有呼吸道症状,175例(17.5%)检出呼吸道病毒。
- 干预组平均住院时长4.2天(SD 5.4),对照组4.1天(SD 4.9),差异0.1(95%CI -0.5至0.6,P=0.810)。
- 干预组平均抗菌药物使用天数11.3天(SD 12.6),对照组10.4天(SD 11.4),差异0.9(95%CI -0.6至2.4,P=0.235)。
临床怎么用
- 对于急诊成人呼吸道症状、发热、胸痛或一般状况差者,不应仅期望通过快速多重病毒PCR检测来减少抗菌药物使用或缩短住院。
- 临床决策仍需综合评估,不能单纯依赖快速病毒检测结果来停用或避免抗菌药物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Inappropriate use of antibiotics is associated with development of antimicrobial resistance. In respiratory infections it is often difficult to differentiate between viral and bacterial infections, and empirical treatment is common. Enhanced viral testing is expected to clarify clinical decision-making and reduce the prescription of antibacterial agents, but the impact of such information on patient care is unclear. METHODS: We conducted a (1:1) randomized controlled clinical trial involving 998 adults with respiratory symptoms, fever, chest pain or poor general condition in the emergency unit of a tertiary hospital. Multiplex PCR results for 496 patients were available in 24 hours (intervention group) and those for the remaining 502 patients were available in 7 days (control group). Our primary outcome measures were the duration of hospitalization and the consumption of antibiotics within 30 days of enrolment. RESULTS: In all, 841 of 998 (84%) patients had respiratory symptoms at study entry. A respiratory virus was detected in 175 (17.5%). The mean duration of hospitalization was 4.2 days (SD 5.4) in the intervention group and 4.1 days (SD 4.9) in the control group (difference 0.1, 95% CI -0.5 to 0.6, p 0.810). The mean days on antibiotics were 11.3 days (SD 12.6) in the intervention group and 10.4 days (SD 11.4) in the control group (difference 0.9, 95% CI -0.6 to 2.4, p 0.235). CONCLUSIONS: Multiplex PCR testing for respiratory viruses with results available within 24 hours did not reduce the consumption of bacterial antibiotics or the length of hospital stay in adults presenting with respiratory symptoms, fever, chest pain or reduced general condition in acute care.
引用
- Saarela E, Tapiainen T, Kauppila J, et al. Impact of multiplex respiratory virus testing on antimicrobial consumption in adults in acute care: a randomized clinical trial. Clin Microbiol Infect. 2019. PMID: 31574339. doi:10.1016/j.cmi.2019.09.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。